MNKD FY 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M-93.3% YoY

Gross Profit

-$5M-46.7% margin

Operating Income

-$108M-921.1% margin

Net Income

-$117M-999.0% margin

EPS (Diluted)

$-1.13

Cash Flow

Operating Cash Flow

-$65M

Free Cash Flow

-$65M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$85M

Total Liabilities

$299M

Stockholders' Equity

-$215M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$175M	-93.3%
Gross Profit	-$5M	$125M	-104.4%
Operating Income	-$108M	$67M	-260.9%
Net Income	-$117M	$126M	-193.4%